Biomedical Optics Express · 2011 · 22 citations · 27 references
MedicineCell BiologyOncologyBiomedical ImagingDiagnostic ImagingMolecular ImagingBreast Cancer ImagingCellular ImagingContrast AgentsFluorescence ImagingFluorescence SpectroscopyMolecular Imaging In OncologyBreast Tissue ImagingCancer ImagingFluorescence Contrast AgentsIn Vivo Fluorescence ImagingMolecular Imaging ProbesOptical ContrastOptical Contrast AgentsSurgical Resection Margins
Rapid in situ determination of surgical resection margins during breast cancer surgery would reduce patient time under anesthesia. We present preliminary data supporting the use of a fluorescent glucose analog (2-NBDG) as an optical contrast agent to differentiate freshly excised breast tissue containing cancerous cells from normal breast tissue. Multi-spectral images of 14 breast cancer specimens acquired before and after incubation with 2-NBDG demonstrated increased fluorescent signal in all of the malignant tissue due to increased 2-NBDG consumption. We demonstrate that 2-NBDG has potential as an optical contrast agent to differentiate cancerous from non-cancerous tissue.
27
THE METABOLISM OF TUMORS IN THE BODY
Otto Warbürg, Franz Wind, Erwin Negelein · The Journal of General Physiology · 1927 · 4.4K citations · Full text
Peter G. Isaacson, Ahmet Doǧan, Stephen K. Price et al. · The American Journal of Surgical Pathology · 1989 · 1.9K citations
Medicine, Endocrinology, Pathology +13